系统综述发现评估多种心脏代谢药物依从性与持续性的指标不一致
该系统综述检索了Medline、Embase和PsycINFO数据库,纳入评估使用多种心脏代谢药物(降压、降脂和/或降糖药)患者依从性和/或持续性的研究。在54项评估依从性的研究中仅36项(67%)清晰描述了所用指标,22项评估持续性的研究中仅6项(27%)清晰描述;研究识别出5种依从性指标和3种持续性指标,不足半数研究在相关时明确考虑换药。结论认为「任何药物」指标最适合识别需要干预的患者,「所有药物」指标适用于评估干预效果,报告和解读多药依从性或持续性估计时需更关注测量定义的充分性。
要点
- 仅67%的依从性研究和27%的持续性研究清晰描述了所用测量指标。
- 识别出5种依从性指标和3种持续性指标,定义不一致影响研究间可比性。
- 「任何药物」指标适合识别需干预患者,「所有药物」指标适合评估干预效果。
核心结论
- 评估多种心脏代谢药物依从性和持续性的测量指标存在不一致,报告和解读时需更关注测量定义的充分性。
研究设计与样本
- 系统综述,检索Medline、Embase和PsycINFO数据库,纳入评估使用多种心脏代谢药物患者依从性和/或持续性的研究,由两名评价者独立完成研究选择。
主要发现
- 54项评估依从性的研究中仅36项(67%)清晰描述了所用指标,识别出5种依从性指标。
- 22项评估持续性的研究中仅6项(27%)清晰描述了所用指标,识别出3种持续性指标。
- 不足半数研究在相关时明确考虑了换药情况。
关键数值与推荐
- 依从性指标包括对「所有」药物、对「任何」药物、对「两者」药物、平均依从性以及最高/最低依从性。
- 持续性指标包括对「所有」药物、对「两者」药物以及对「任何」药物的持续性。
- 「任何药物」指标最适合识别需要干预的患者,「所有药物」指标适用于评估干预效果。
临床怎么用
- 选择依从性/持续性指标时应根据目的:识别需干预患者可用「任何药物」指标,评估干预效果可用「所有药物」指标。
- 报告依从性或持续性估计时应清晰描述测量定义,并在相关时明确说明换药的处理方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We reviewed measures used to estimate adherence and persistence to multiple cardiometabolic medications from prescription data, particularly for blood pressure-lowering, lipid-lowering, and/or glucose-lowering medication, and give guidance on which measures to choose. STUDY DESIGN AND SETTING: A literature search of Medline, Embase, and PsycINFO databases was conducted to identify studies assessing medication adherence and/or persistence for patients using multiple cardiometabolic medications. Two reviewers performed the study selection process independently. RESULTS: From the 54 studies assessing adherence, only 36 (67%) clearly described the measures used. Five measures for adherence were identified, including adherence to "all," to "any," to "both" medication, "average adherence," and "highest/lowest adherence". From the 22 studies assessing persistence, only six (27%) clearly described the measures used. Three measures for persistence were identified, including persistence with "all," with "both," and with "any" medication. Less than half of the studies explicitly considered medication switches when relevant. CONCLUSION: From the identified measures, the "any medication" measure is most suitable for identifying patients in need of an intervention, whereas the "all medication" measure is useful for assessing the effect of interventions. More attention is needed for adequate measurement definitions when reporting on and interpreting adherence or persistence estimates to multiple medications.
引用
- Alfian SD, Pradipta IS, Hak E, et al. A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications. J Clin Epidemiol. 2018. PMID: 30537541. doi:10.1016/j.jclinepi.2018.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。